EdenteV2, Istex, Corpus, bibRecord, 003261

CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA

Identifieur interne : 003261 ( Istex/Corpus ); précédent : 003260; suivant : 003262

CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA

Auteurs : Mita Giacomini ; Fiona Miller ; George Browman

Source :

International Journal of Technology Assessment in Health Care [ 0266-4623 ] ; 2003-04.

RBID : ISTEX:66A51E6F143F6F7472575C3D406F14AB522BFB33

Abstract

We describe an evaluation model to guide public coverage of new predictive genetic tests in Ontario, Canada. The model confronts common “gray zones” in evaluation and coverage policy for challenging new technologies. Analysis addresses three domains of the evaluation picture. The first specifies evaluative criteria (purpose, effectiveness, additional effects, unit cost, demand, cost-effectiveness). The second induces or deduces acceptable cutoffs for each criterion. The third domain addresses the need to make decisions under uncertainty and to respond to “gray” evaluations with conditional-coverage decisions. The evaluation criteria should be applied within sound decision-making processes.

Url:

https://api.istex.fr/document/66A51E6F143F6F7472575C3D406F14AB522BFB33/fulltext/pdf

DOI: 10.1017/S0266462303000278

Links to Exploration step

ISTEX:66A51E6F143F6F7472575C3D406F14AB522BFB33

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA</title>
<author><name sortKey="Giacomini, Mita" sort="Giacomini, Mita" uniqKey="Giacomini M" first="Mita" last="Giacomini">Mita Giacomini</name>
<affiliation><mods:affiliation>McMaster University</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Miller, Fiona" sort="Miller, Fiona" uniqKey="Miller F" first="Fiona" last="Miller">Fiona Miller</name>
<affiliation><mods:affiliation>McMaster University</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Browman, George" sort="Browman, George" uniqKey="Browman G" first="George" last="Browman">George Browman</name>
<affiliation><mods:affiliation>McMaster University, Hamilton Regional Cancer Centre</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:66A51E6F143F6F7472575C3D406F14AB522BFB33</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1017/S0266462303000278</idno>
<idno type="url">https://api.istex.fr/document/66A51E6F143F6F7472575C3D406F14AB522BFB33/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003261</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003261</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA</title>
<author><name sortKey="Giacomini, Mita" sort="Giacomini, Mita" uniqKey="Giacomini M" first="Mita" last="Giacomini">Mita Giacomini</name>
<affiliation><mods:affiliation>McMaster University</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Miller, Fiona" sort="Miller, Fiona" uniqKey="Miller F" first="Fiona" last="Miller">Fiona Miller</name>
<affiliation><mods:affiliation>McMaster University</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Browman, George" sort="Browman, George" uniqKey="Browman G" first="George" last="Browman">George Browman</name>
<affiliation><mods:affiliation>McMaster University, Hamilton Regional Cancer Centre</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">International Journal of Technology Assessment in Health Care</title>
<idno type="ISSN">0266-4623</idno>
<idno type="eISSN">1471-6348</idno>
<imprint><publisher>Cambridge University Press</publisher>
<pubPlace>New York, USA</pubPlace>
<date type="published" when="2003-04">2003-04</date>
<biblScope unit="volume">19</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="301">301</biblScope>
<biblScope unit="page" to="316">316</biblScope>
</imprint>
<idno type="ISSN">0266-4623</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0266-4623</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">We describe an evaluation model to guide public coverage of new predictive genetic tests in Ontario, Canada. The model confronts common “gray zones” in evaluation and coverage policy for challenging new technologies. Analysis addresses three domains of the evaluation picture. The first specifies evaluative criteria (purpose, effectiveness, additional effects, unit cost, demand, cost-effectiveness). The second induces or deduces acceptable cutoffs for each criterion. The third domain addresses the need to make decisions under uncertainty and to respond to “gray” evaluations with conditional-coverage decisions. The evaluation criteria should be applied within sound decision-making processes.</div>
</front>
</TEI>
<istex><corpusName>cambridge</corpusName>
<author><json:item><name>Mita Giacomini</name>
<affiliations><json:string>McMaster University</json:string>
</affiliations>
</json:item>
<json:item><name>Fiona Miller</name>
<affiliations><json:string>McMaster University</json:string>
</affiliations>
</json:item>
<json:item><name>George Browman</name>
<affiliations><json:string>McMaster University, Hamilton Regional Cancer Centre</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>Decision making</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Organizational</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Health priorities/*organization & administration</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Technology assessment</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Biomedical/*organization & administration</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Health care rationing</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Genetics/legislation & jurisprudence</value>
</json:item>
</subject>
<arkIstex>ark:/67375/6GQ-KJQZ56PW-1</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>research-article</json:string>
</originalGenre>
<abstract>We describe an evaluation model to guide public coverage of new predictive genetic tests in Ontario, Canada. The model confronts common “gray zones” in evaluation and coverage policy for challenging new technologies. Analysis addresses three domains of the evaluation picture. The first specifies evaluative criteria (purpose, effectiveness, additional effects, unit cost, demand, cost-effectiveness). The second induces or deduces acceptable cutoffs for each criterion. The third domain addresses the need to make decisions under uncertainty and to respond to “gray” evaluations with conditional-coverage decisions. The evaluation criteria should be applied within sound decision-making processes.</abstract>
<qualityIndicators><score>8.116</score>
<pdfWordCount>7951</pdfWordCount>
<pdfCharCount>52903</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>16</pdfPageCount>
<pdfPageSize>486 x 720 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractWordCount>93</abstractWordCount>
<abstractCharCount>698</abstractCharCount>
<keywordCount>7</keywordCount>
</qualityIndicators>
<title>CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA</title>
<pii><json:string>S0266462303000278</json:string>
</pii>
<genre><json:string>research-article</json:string>
</genre>
<host><title>International Journal of Technology Assessment in Health Care</title>
<language><json:string>unknown</json:string>
</language>
<issn><json:string>0266-4623</json:string>
</issn>
<eissn><json:string>1471-6348</json:string>
</eissn>
<publisherId><json:string>THC</json:string>
</publisherId>
<volume>19</volume>
<issue>2</issue>
<pages><first>301</first>
<last>316</last>
<total>16</total>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<ark><json:string>ark:/67375/6GQ-KJQZ56PW-1</json:string>
</ark>
<publicationDate>2003</publicationDate>
<copyrightDate>2003</copyrightDate>
<doi><json:string>10.1017/S0266462303000278</json:string>
</doi>
<id>66A51E6F143F6F7472575C3D406F14AB522BFB33</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/66A51E6F143F6F7472575C3D406F14AB522BFB33/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/66A51E6F143F6F7472575C3D406F14AB522BFB33/fulltext/zip</uri>
</json:item>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/66A51E6F143F6F7472575C3D406F14AB522BFB33/fulltext/txt</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/66A51E6F143F6F7472575C3D406F14AB522BFB33/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA</title>
<respStmt><resp>Références bibliographiques récupérées via GROBID</resp>
<name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name>
</respStmt>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher scheme="https://publisher-list.data.istex.fr">Cambridge University Press</publisher>
<pubPlace>New York, USA</pubPlace>
<availability><licence><p>© 2003 Cambridge University Press</p>
</licence>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-G3RCRD03-V">cambridge</p>
</availability>
<date>2003-06-18</date>
</publicationStmt>
<notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a">CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA</title>
<author xml:id="author-0000"><persName><forename type="first">Mita</forename>
<surname>Giacomini</surname>
</persName>
<affiliation>McMaster University</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">Fiona</forename>
<surname>Miller</surname>
</persName>
<affiliation>McMaster University</affiliation>
</author>
<author xml:id="author-0002"><persName><forename type="first">George</forename>
<surname>Browman</surname>
</persName>
<affiliation>McMaster University, Hamilton Regional Cancer Centre</affiliation>
</author>
<idno type="istex">66A51E6F143F6F7472575C3D406F14AB522BFB33</idno>
<idno type="ark">ark:/67375/6GQ-KJQZ56PW-1</idno>
<idno type="DOI">10.1017/S0266462303000278</idno>
<idno type="PII">S0266462303000278</idno>
</analytic>
<monogr><title level="j">International Journal of Technology Assessment in Health Care</title>
<idno type="pISSN">0266-4623</idno>
<idno type="eISSN">1471-6348</idno>
<idno type="publisher-id">THC</idno>
<imprint><publisher>Cambridge University Press</publisher>
<pubPlace>New York, USA</pubPlace>
<date type="published" when="2003-04"></date>
<biblScope unit="volume">19</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="301">301</biblScope>
<biblScope unit="page" to="316">316</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>2003-06-18</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract style="normal"><p>We describe an evaluation model to guide public coverage of new predictive genetic tests in Ontario, Canada. The model confronts common “gray zones” in evaluation and coverage policy for challenging new technologies. Analysis addresses three domains of the evaluation picture. The first specifies evaluative criteria (purpose, effectiveness, additional effects, unit cost, demand, cost-effectiveness). The second induces or deduces acceptable cutoffs for each criterion. The third domain addresses the need to make decisions under uncertainty and to respond to “gray” evaluations with conditional-coverage decisions. The evaluation criteria should be applied within sound decision-making processes.</p>
</abstract>
<textClass><keywords scheme="keyword"><list><head>keywords</head>
<item><term>Decision making</term>
</item>
<item><term>Organizational</term>
</item>
<item><term>Health priorities/*organization & administration</term>
</item>
<item><term>Technology assessment</term>
</item>
<item><term>Biomedical/*organization & administration</term>
</item>
<item><term>Health care rationing</term>
</item>
<item><term>Genetics/legislation & jurisprudence</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="2003-06-18">Created</change>
<change when="2003-04">Published</change>
<change xml:id="refBibs-istex" who="#ISTEX-API" when="2017-09-5">References added</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
</fulltext>
<metadata><istex:metadataXml wicri:clean="corpus cambridge not found" wicri:toSee="no header"><istex:xmlDeclaration>version='1.0' encoding='UTF-8'</istex:xmlDeclaration>
<istex:docType PUBLIC="-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" URI="JATS-journalpublishing1.dtd" name="istex:docType"></istex:docType>
<istex:document><article dtd-version="1.0" article-type="research-article"><front><journal-meta><journal-id journal-id-type="publisher-id">THC</journal-id>
<journal-title-group><journal-title>International Journal of Technology Assessment in Health Care</journal-title>
<abbrev-journal-title>Int J Technol Assess Health Care</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1471-6348</issn>
<issn pub-type="ppub">0266-4623</issn>
<publisher><publisher-name>Cambridge University Press</publisher-name>
<publisher-loc>New York, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pii">S0266462303000278</article-id>
<article-id pub-id-type="doi">10.1017/S0266462303000278</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>GENERAL ESSAYS</subject>
</subj-group>
</article-categories>
<title-group><article-title>CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA</article-title>
</title-group>
<contrib-group><contrib><name><surname>Giacomini</surname>
<given-names>Mita</given-names>
</name>
<aff><institution>McMaster University</institution>
</aff>
</contrib>
<contrib><name><surname>Miller</surname>
<given-names>Fiona</given-names>
</name>
<aff><institution>McMaster University</institution>
</aff>
</contrib>
<contrib><name><surname>Browman</surname>
<given-names>George</given-names>
</name>
<aff><institution>McMaster University</institution>
, Hamilton Regional Cancer Centre</aff>
</contrib>
</contrib-group>
<pub-date pub-type="epub"><day>18</day>
<month>6</month>
<year>2003</year>
</pub-date>
<pub-date pub-type="ppub"><month>4</month>
<year>2003</year>
</pub-date>
<volume>19</volume>
<issue>2</issue>
<fpage>301</fpage>
<lpage>316</lpage>
<permissions><copyright-statement>© 2003 Cambridge University Press</copyright-statement>
</permissions>
<abstract abstract-type="normal"><p>We describe an evaluation model to guide public coverage of new predictive genetic tests in Ontario, Canada. The model confronts common “gray zones” in evaluation and coverage policy for challenging new technologies. Analysis addresses three domains of the evaluation picture. The first specifies evaluative criteria (purpose, effectiveness, additional effects, unit cost, demand, cost-effectiveness). The second induces or deduces acceptable cutoffs for each criterion. The third domain addresses the need to make decisions under uncertainty and to respond to “gray” evaluations with conditional-coverage decisions. The evaluation criteria should be applied within sound decision-making processes.</p>
</abstract>
<kwd-group><kwd>Decision making</kwd>
<kwd>Organizational</kwd>
<kwd>Health priorities/*organization & administration</kwd>
<kwd>Technology assessment</kwd>
<kwd>Biomedical/*organization & administration</kwd>
<kwd>Health care rationing</kwd>
<kwd>Genetics/legislation & jurisprudence</kwd>
</kwd-group>
<counts><page-count count="16"></page-count>
</counts>
<custom-meta-group><custom-meta><meta-name>pdf</meta-name>
<meta-value>S0266462303000278a.pdf</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo><title>CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA"><title>CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA</title>
</titleInfo>
<name type="personal"><namePart type="given">Mita</namePart>
<namePart type="family">Giacomini</namePart>
<affiliation>McMaster University</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Fiona</namePart>
<namePart type="family">Miller</namePart>
<affiliation>McMaster University</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">George</namePart>
<namePart type="family">Browman</namePart>
<affiliation>McMaster University, Hamilton Regional Cancer Centre</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="research-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo><publisher>Cambridge University Press</publisher>
<place><placeTerm type="text">New York, USA</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2003-04</dateIssued>
<dateCreated encoding="w3cdtf">2003-06-18</dateCreated>
<copyrightDate encoding="w3cdtf">2003</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<abstract type="normal">We describe an evaluation model to guide public coverage of new predictive genetic tests in Ontario, Canada. The model confronts common “gray zones” in evaluation and coverage policy for challenging new technologies. Analysis addresses three domains of the evaluation picture. The first specifies evaluative criteria (purpose, effectiveness, additional effects, unit cost, demand, cost-effectiveness). The second induces or deduces acceptable cutoffs for each criterion. The third domain addresses the need to make decisions under uncertainty and to respond to “gray” evaluations with conditional-coverage decisions. The evaluation criteria should be applied within sound decision-making processes.</abstract>
<subject><genre>keywords</genre>
<topic>Decision making</topic>
<topic>Organizational</topic>
<topic>Health priorities/*organization & administration</topic>
<topic>Technology assessment</topic>
<topic>Biomedical/*organization & administration</topic>
<topic>Health care rationing</topic>
<topic>Genetics/legislation & jurisprudence</topic>
</subject>
<relatedItem type="host"><titleInfo><title>International Journal of Technology Assessment in Health Care</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<identifier type="ISSN">0266-4623</identifier>
<identifier type="eISSN">1471-6348</identifier>
<identifier type="PublisherID">THC</identifier>
<part><date>2003</date>
<detail type="volume"><caption>vol.</caption>
<number>19</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>2</number>
</detail>
<extent unit="pages"><start>301</start>
<end>316</end>
<total>16</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">66A51E6F143F6F7472575C3D406F14AB522BFB33</identifier>
<identifier type="ark">ark:/67375/6GQ-KJQZ56PW-1</identifier>
<identifier type="DOI">10.1017/S0266462303000278</identifier>
<identifier type="PII">S0266462303000278</identifier>
<accessCondition type="use and reproduction" contentType="copyright">© 2003 Cambridge University Press</accessCondition>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-G3RCRD03-V">cambridge</recordContentSource>
<recordOrigin>© 2003 Cambridge University Press</recordOrigin>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/document/66A51E6F143F6F7472575C3D406F14AB522BFB33/metadata/json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003261 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003261 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:66A51E6F143F6F7472575C3D406F14AB522BFB33
   |texte=   CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA
}}

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022

	Serveur d'exploration sur le patient édenté
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le patient édenté

CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA

CONFRONTING THE “GRAY ZONES” OF TECHNOLOGY ASSESSMENT: EVALUATING GENETIC TESTING SERVICES FOR PUBLIC INSURANCE COVERAGE IN CANADA

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri